![Vincent Lawton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 130 190 $ al 31/07/2026
Vincent M.
Lawton is the founder of United Kingdom Department of Health & Social Care, Pharmaceutical Industry Competitiveness Task Force, UK Clinical Research Collaboration.
Current jobs include Chairman at Addex Therapeutics Ltd., Chairman at AQIX Ltd., and Director at Neurosterix SA. Former jobs include Managing Director at Organon Pharma (UK) Ltd., Non-Executive Director at Medicines & Healthcare Products Regulatory Agency from 2008 to 2015, President at The Association of the British Pharmaceutical Industry from 2004 to 2006, Founding Member at Ministerial Industry Strategy Group, and Vice President at Merck & Co., Inc. Education includes undergraduate and doctorate degrees from the University of London.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ADDEX THERAPEUTICS LTD 1,15 % | 18/03/2026 | 2.507.987 ( 1,15 % ) | 130 190 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ADDEX THERAPEUTICS LTD | Presidente | - |
AQIX Ltd.
 AQIX Ltd. Pharmaceuticals: MajorHealth Technology Provides fluid technology for maintaining homeostasis at cellular, tissue, and organ levels | Presidente | - |
| Empresas | Cargo | Fin |
|---|---|---|
Medicines & Healthcare Products Regulatory Agency
 Medicines & Healthcare Products Regulatory Agency General GovernmentGovernment Regulates medicines, medical devices and equipment of healthcare to safeguard the public health | Director/Miembro de la Junta | 01/01/2015 |
Organon Pharma (UK) Ltd.
 Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales women's health products | Director Ejecutivo | 01/01/2006 |
The Association of the British Pharmaceutical Industry
 The Association of the British Pharmaceutical Industry Miscellaneous Commercial ServicesCommercial Services Operates pharmaceutical companies associations | Presidente | 01/01/2006 |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Ministerial Industry Strategy Group | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 11 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
United Kingdom Department of Health & Social Care
 United Kingdom Department of Health & Social Care General GovernmentGovernment Functions as a health and social care department | Government |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Organon Pharma (UK) Ltd.
Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales women's health products | Health Technology |
Addex Therapeutics Ltd.
 Addex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs | Health Technology |
The Association of the British Pharmaceutical Industry
The Association of the British Pharmaceutical Industry Miscellaneous Commercial ServicesCommercial Services Operates pharmaceutical companies associations | Commercial Services |
AQIX Ltd.
AQIX Ltd. Pharmaceuticals: MajorHealth Technology Provides fluid technology for maintaining homeostasis at cellular, tissue, and organ levels | Health Technology |
Medicines & Healthcare Products Regulatory Agency
Medicines & Healthcare Products Regulatory Agency General GovernmentGovernment Regulates medicines, medical devices and equipment of healthcare to safeguard the public health | Government |
Pharmaceutical Industry Competitiveness Task Force
 Pharmaceutical Industry Competitiveness Task Force General GovernmentGovernment Identifies and reports to the prime minister to retain and strengthen the competitiveness of pharmaceutical industry | Government |
UK Clinical Research Collaboration | |
Ministerial Industry Strategy Group |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
